Follow
Clemens Wittwehr
Clemens Wittwehr
Verified email at ec.europa.eu
Title
Cited by
Cited by
Year
How adverse outcome pathways can aid the development and use of computational prediction models for regulatory toxicology
C Wittwehr, H Aladjov, G Ankley, HJ Byrne, J de Knecht, E Heinzle, ...
Toxicological Sciences 155 (2), 326-336, 2017
1642017
t4 workshop report: pathways of toxicity
A Kleensang, A Maertens, M Rosenberg, S Fitzpatrick, J Lamb, ...
Altex 31 (1), 53, 2014
1082014
Alternative methods for regulatory toxicology–a state-of-the-art review
A Worth, J Barroso, S Bremer, J Burton, S Casati, S Coecke, R Corvi, ...
JRC Sci Policy Rep EUR 26797, 1-475, 2014
662014
Creating a structured adverse outcome pathway knowledgebase via ontology-based annotations
C Ives, I Campia, RL Wang, C Wittwehr, S Edwards
Applied in vitro toxicology 3 (4), 298-311, 2017
602017
EURL ECVAM status report on the development, validation and regulatory acceptance of alternative methods and approaches (2019)
D Asturiol Bofill
Publications Office of the European Union, 2020
502020
Artificial Intelligence for chemical risk assessment
C Wittwehr, P Blomstedt, JP Gosling, T Peltola, B Raffael, AN Richarz, ...
Computational Toxicology 13, 100114, 2020
382020
diXa: a data infrastructure for chemical safety assessment
DM Hendrickx, HJWL Aerts, F Caiment, D Clark, TMD Ebbels, CT Evelo, ...
Bioinformatics 31 (9), 1505-1507, 2015
382015
Application of AOPs to assist regulatory assessment of chemical risks–Case studies, needs and recommendations
L Bajard, O Adamovsky, K Audouze, K Baken, R Barouki, JB Beltman, ...
Environmental Research 217, 114650, 2023
302023
Systematic organization of COVID-19 data supported by the adverse outcome pathway framework
P Nymark, M Sachana, SB Leite, J Sund, CE Krebs, K Sullivan, ...
Frontiers in public health 9, 638605, 2021
292021
Towards a qAOP framework for predictive toxicology-Linking data to decisions
A Paini, I Campia, MTD Cronin, D Asturiol, L Ceriani, TE Exner, W Gao, ...
Computational Toxicology 21, 100195, 2022
192022
Non-animal methods in science and regulation
V ZUANG, A DURA, LE AHS, J BARROSO, LS BATISTA, E BERGGREN, ...
192022
Understanding COVID-19 through adverse outcome pathways–2nd CIAO AOP Design Workshop
C Wittwehr, MJ Amorim, LA Clerbaux, C Krebs, B Landesmann, ...
ALTEX-Alternatives to animal experimentation 38 (2), 351-357, 2021
172021
Alzheimer’s disease, and breast and prostate cancer research: Translational failures and the importance to monitor outputs and impact of funded research
F Pistollato, C Bernasconi, J McCarthy, I Campia, C Desaintes, C Wittwehr, ...
Animals 10 (7), 1194, 2020
172020
COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease–3rd CIAO AOP Design Workshop
LA Clerbaux, N Amigó, MJ Amorim, A Bal-Price, SB Leite, A Beronius, ...
Altex 39 (2), 322–335, 2022
152022
The adverse outcome pathway: a conceptual framework to support toxicity testing in the twenty-first century
E Perkins, N Garcia-Reyero, S Edwards, C Wittwehr, D Villeneuve, ...
Computational systems toxicology, 1-26, 2015
152015
Addressing evidence needs in chemicals policy and regulation
A CARUSI, C WITTWEHR, M WHELAN
112022
Bridging across methods in the biosciences
A CARUSI, M WHELAN, C WITTWEHR
112019
Accelerating progress in the replacement, reduction and refinement of animal testing through better knowledge sharing
T Holley, G Bowe, I Campia, S Belz, E Berggren, A Janusch-Roi, ...
Publications Office of the European Union, 2016
112016
OECD harmonised template 201: Structuring and reporting mechanistic information to foster the integration of new approach methodologies for hazard and risk assessment of chemicals
E Carnesecchi, I Langezaal, P Browne, S Batista-Leite, I Campia, ...
Regulatory Toxicology and Pharmacology, 105426, 2023
82023
The adverse outcome pathway framework applied to neurological symptoms of COVID-19
HT Hogberg, A Lam, E Ohayon, MA Shahbaz, LA Clerbaux, A Bal-Price, ...
Cells 11 (21), 3411, 2022
82022
The system can't perform the operation now. Try again later.
Articles 1–20